Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,314 | 357 | 78.1% |
| Travel and Lodging | $1,379 | 4 | 20.3% |
| Education | $101.93 | 3 | 1.5% |
| Gift | $5.61 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,809 | 13 | $0 (2018) |
| Lundbeck LLC | $801.69 | 81 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $746.44 | 46 | $0 (2022) |
| ABBVIE INC. | $622.80 | 37 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $376.94 | 24 | $0 (2024) |
| Alkermes, Inc. | $371.09 | 22 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $371.00 | 21 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $358.64 | 28 | $0 (2023) |
| Allergan, Inc. | $326.41 | 34 | $0 (2020) |
| Indivior Inc. | $179.79 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $687.09 | 36 | ABBVIE INC. ($108.36) |
| 2023 | $773.39 | 45 | AbbVie Inc. ($242.81) |
| 2022 | $540.51 | 33 | ABBVIE INC. ($198.45) |
| 2021 | $227.87 | 14 | AbbVie Inc. ($73.18) |
| 2020 | $394.94 | 20 | Sunovion Pharmaceuticals Inc. ($311.41) |
| 2019 | $594.35 | 55 | Janssen Pharmaceuticals, Inc ($139.37) |
| 2018 | $2,771 | 104 | Abbott Laboratories ($1,809) |
| 2017 | $811.31 | 58 | Sunovion Pharmaceuticals Inc. ($279.16) |
All Payment Transactions
365 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $36.93 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/03/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Opioid Use Disorder | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Neuropsychiatry | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Neurology | ||||||
| 08/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: CNS | ||||||
| 07/29/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $20.50 | General |
| Category: PSYCHIATRY | ||||||
| 07/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: PSYCHIATRY | ||||||
| 06/14/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Central Nervous System | ||||||
| 05/24/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: CNS | ||||||
| 05/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: PSYCHIATRY | ||||||
| 05/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: PSYCHIATRY | ||||||
| 05/09/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: BH | ||||||
| 05/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/25/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: PSYCHIATRY | ||||||
| 04/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: CNS | ||||||
| 04/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Neurology | ||||||
| 03/26/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Central Nervous System | ||||||
| 03/13/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 3 | 34 | 44 | $9,797 | $2,387 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 12 | 16 | $3,975 | $1,068 | 26.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 17 | $3,132 | $808.16 | 25.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 11 | $2,690 | $510.70 | 19.0% |
About Dr. Katherine Schmidt, MD
Dr. Katherine Schmidt, MD is a Addiction Medicine healthcare provider based in Walnut Hills, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457440802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Katherine Schmidt, MD has received a total of $6,800 in payments from pharmaceutical and medical device companies, with $687.09 received in 2024. These payments were reported across 365 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($5,314).
As a Medicare-enrolled provider, Schmidt has provided services to 34 Medicare beneficiaries, totaling 44 services with total Medicare billing of $2,387. Data is available for 1 year (2020–2020), covering 3 distinct procedure/service records.
Practice Information
- Specialty Addiction Medicine
- Other Specialties Psychiatry, General Practice
- Location Walnut Hills, OH
- Active Since 10/12/2006
- Last Updated 04/15/2020
- Taxonomy Code 2084A0401X
- Entity Type Individual
- NPI Number 1457440802
Products in Payments
- Pacemakers (Device) $1,422
- VRAYLAR (Drug) $949.21
- LATUDA (Drug) $746.44
- ABILIFY MAINTENA (Drug) $591.21
- REXULTI (Drug) $333.39
- INVEGA SUSTENNA (Drug) $305.04
- Fortify Assura, Ellipse ICD (Device) $276.31
- INGREZZA (Drug) $167.11
- ARISTADA (Drug) $166.76
- AUSTEDO (Drug) $153.78
- TRINTELLIX (Drug) $152.36
- SUBLOCADE (Drug) $140.29
- Aristada 441 mg (Drug) $118.56
- CAPLYTA (Drug) $115.90
- Auvelity (Drug) $111.49
- ABILIFY ASIMTUFII (Drug) $108.84
- Assurity Pacemaker (Device) $85.88
- BRINTELLIX (Drug) $72.73
- UZEDY (Drug) $71.40
- HETLIOZ (Drug) $64.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.